Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposium.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 09 02 2020
accepted: 05 05 2020
pubmed: 15 5 2020
medline: 19 8 2020
entrez: 15 5 2020
Statut: ppublish

Résumé

The role of mobile health (mHealth) technology in cancer care has evolved alongside the rapid development in digital technology. Its use can come with significant potential benefits; however, such use may also be associated with risks. This paper summarizes the latest developments around mHealth use in cancer care presented by a panel of experts at the 2019 Annual Meeting of the Multinational Association of Supportive Care in Cancer. Through lectures, case studies, and panel discussions, speakers and participants (including cancer specialist doctors, nurses, and allied health professionals) evaluated current and emerging mHealth methods for supportive care in cancer survivorship. Focus areas and special considerations were agreed upon by consensus. Three focus areas for the use of mHealth in cancer care were identified: activation and support of self-management, exercise oncology, and enablement of survivorship care delivery. In addition to these focus areas, two special considerations were highlighted: technology-enhanced supportive cancer care for disparate populations, and ethical considerations relevant to the use of technology in supportive care. mHealth has the potential to revolutionize and transform cancer care delivery. Future research should guide further advances in the use of technology in supportive cancer care and carefully explore the safety, efficacy, cost-effectiveness, and implementation of interventions delivered through mHealth platforms.

Identifiants

pubmed: 32405966
doi: 10.1007/s00520-020-05513-x
pii: 10.1007/s00520-020-05513-x
doi:

Types de publication

Historical Article Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4059-4067

Auteurs

Raymond J Chan (RJ)

School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Level 3, N Block, Brisbane, 4059, Australia. Raymond.Chan@qut.edu.au.
Division of Cancer Services, Princess Alexandra Hospital, Metro South Hospital and Health Services, Brisbane, Australia. Raymond.Chan@qut.edu.au.

Doris Howell (D)

Department of Supportive Care, Princess Margaret Cancer Research Center and Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada.

Maryam B Lustberg (MB)

College of Medicine, The Ohio State Comprehensive Cancer Center, Columbus, OH, USA.

Karen Mustian (K)

Department of Surgery, Wilmot Cancer Institute, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA.

Bogda Koczwara (B)

Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, Australia.

Chiu Chin Ng (CC)

Department of Pharmacy, National University of Singapore, Singapore, Singapore.

Yoon Kim (Y)

Department of Physical Medicine and Rehabilitation, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Anna María Nápoles (AM)

Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA.

Niharika Dixit (N)

Department of Medicine, Division of Hematology and Oncology, University of California San Francisco/Zuckerberg San Francisco General Hospital, San Francisco, CA, USA.

Dori Klemanski (D)

Wexner Medical Center, The Ohio State University, Columbus, OH, USA.

Yu Ke (Y)

Department of Pharmacy, National University of Singapore, Singapore, Singapore.

Yi Long Toh (YL)

Department of Pharmacy, National University of Singapore, Singapore, Singapore.

Margaret I Fitch (MI)

Lawrence S. Bloomberg, Faculty of Nursing, University of Toronto, Toronto, Canada.

Megan Crichton (M)

School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Level 3, N Block, Brisbane, 4059, Australia.

Sangeeta Agarawal (S)

Helpsyhealth.com and University of California San Francisco, San Francisco, CA, USA.

Alexandre Chan (A)

Department of Clinical Pharmacy Practice, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, 101 Theory, Suite 100, Irvine, CA, 92697-3958, USA. a.chan@uci.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH